Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer

NCT06677762 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ruijin Hospital